Mode
Text Size
Log in / Sign up
N/A N=51 Randomized Prevention

Marijuana Use, Strength Training, and Alcohol Consumption (MUSTAC) Study

Chronic Pain

Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcome: Primary: Alcohol Demand: Breakpoint — -6.00; -2.07; -1.81; -1.09 dollars/drink — p=.26

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Eccentric Biceps Flexion (Behavioral); Concentric Biceps Flexion (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
University of Florida
Primary completion
May 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Alcohol Demand: Breakpoint
-6.00; -2.07; -1.81; -1.09 .26
PRIMARY
Alcohol Demand: Omax
-.255; -.089; -.03; -.168 .11
PRIMARY
Alcohol Demand: Pmax
-.19; -.080; .0054; -.11 .17
PRIMARY
Alcohol Demand: Essential Value
-.18; -.072; -.24; -.073 .91
PRIMARY
Cannabis Demand: Intensity
-.019; .12; -.070; -.10 .14
PRIMARY
Cannabis Demand: Breakpoint
.40; -.14; -.36; -.80 .83
PRIMARY
Cannabis Demand: Omax
.019; -.010; -.001; -.10 .15
PRIMARY
Cannabis Demand: Pmax
.0005; -.043; .014; -.10 .24
PRIMARY
Cannabis Demand: Essential Value
-.061; .059; -.032; .15 .97
PRIMARY
Alcohol Demand: Intensity
-.094; .047; .0958; -.07 .04 sig

Summary

Self-medication of pain by consuming alcohol and marijuana is common. However, the research regarding pain as a determinant for alcohol and marijuana use has relied on laboratory pain induction paradigms with limited clinical relevance. The study will assess demand for alcohol and marijuana before and after delayed onset muscle soreness (DOMS) induction in co-users. This will provide a clinically relevant, but time-limited, model for the effects of musculoskeletal pain on demand.

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 21 years;
  • English-speaking
  • Self-identify as White/Caucasian or Black/African American
  • Own a smartphone with cellular/data plan
  • Regularly co-use alcohol and smoked marijuana as indicated by scores of ≥3 on item 1 of the CUDIT-R and AUDIT.
  • Willing and able to give informed consent

Exclusion Criteria

  • Participation in biceps-specific conditioning program in the past 6 months*
  • Self-reported wrist/hand, elbow, or shoulder pain the past 3 months
  • Chronic medical condition that may affect pain perception (e.g. diabetes, fibromyalgia, headaches)
  • Self-reported kidney dysfunction, muscle damage, or major psychiatric disorder
  • Medical marijuana prescription
  • Consumption of marijuana using only non-inhalational methods (e.g. edibles, tinctures, or cannabidiol oil)
  • Score of ≥ 10 on Patient Health Questionnaire-9 (moderate depression)
  • Women who are pregnant, trying to become pregnant, or breastfeeding
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04791917). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search